Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of the fiscal period ended Tuesday, September 30, 2025.
Reported quarterly operating margin; no daily interpolation. Q2 FY2025 (2025-09-30): 0.00%.
OPERATING MARGIN
N/A
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Psyence Biomedical Ltd.
Market Cap
$97282.00
Operating Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$108729.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$71110.00
Operating Margin
-29335.29%
TTM Avg
-14667.65%
3Y Avg
-9912.02%
5Y Avg
-6608.01%
Market Cap
$61495.00
Operating Margin
-1930.99%
TTM Avg
-1227.39%
3Y Avg
-922.58%
5Y Avg
-15113.51%
Market Cap
$31083.00
Operating Margin
-54.43%
TTM Avg
-28.29%
3Y Avg
-36.45%
5Y Avg
-20.47%
Market Cap
$30509.00
Operating Margin
-46.36%
TTM Avg
-78.86%
3Y Avg
-46.57%
5Y Avg
-42.21%
Market Cap
$6115.00
Operating Margin
N/A
TTM Avg
-124.15%
3Y Avg
-60.19%
5Y Avg
-47.19%
Market Cap
$242924.00
Operating Margin
-1022.08%
TTM Avg
-791.13%
3Y Avg
-582.66%
5Y Avg
-578.16%
Market Cap
$380715.00
Operating Margin
-51515.17%
TTM Avg
-74429.96%
3Y Avg
-54994.21%
5Y Avg
-36749.57%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Psyence Biomedical Ltd. (PBM) | $97282.00 | N/A | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108729.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| PRF Technologies Ltd. (PRFX)vs › | $71110.00 | -29335.29% | -14667.65% | -9912.02% | -6608.01% |
| Akanda Corp. (AKAN)vs › | $61495.00 | -1930.99% | -1227.39% | -922.58% | -15113.51% |
| Zhongchao Inc. (ZCMD)vs › | $31083.00 | -54.43% | -28.29% | -36.45% | -20.47% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | -46.36% | -78.86% | -46.57% | -42.21% |
| NewGenIvf Group Limited (NIVF)vs › | $6115.00 | N/A | -124.15% | -60.19% | -47.19% |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | -1022.08% | -791.13% | -582.66% | -578.16% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -51515.17% | -74429.96% | -54994.21% | -36749.57% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | -952.12% | -1206.12% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-09-30 | 0.00% |
| 2024-09-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
